Working… Menu

Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02999984
Recruitment Status : Completed
First Posted : December 21, 2016
Last Update Posted : April 13, 2020
California Institute for Regenerative Medicine (CIRM)
University of California, Los Angeles
Information provided by (Responsible Party):
Orchard Therapeutics